Insulin Delivery Pipeline Report 2024 - Stages Of Development, Segments, Regulatory Path And Key Companies

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The "Insulin Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" report has been added to ResearchAndMarkets.com's offering.
The Medical Devices sector report provides comprehensive information about the Insulin Delivery pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Report Scope

• Extensive coverage of the Insulin Delivery under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Insulin Delivery and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

The report enables you to:

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Insulin Delivery under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Insulin Delivery Overview
3 Products under Development
3.1 Insulin Delivery - Pipeline Products by Stage of Development
3.2 Insulin Delivery - Pipeline Products by Segment
3.3 Insulin Delivery - Pipeline Products by Territory
3.4 Insulin Delivery - Pipeline Products by Regulatory Path
3.5 Insulin Delivery - Pipeline Products by Estimated Approval Date
3.6 Insulin Delivery - Ongoing Clinical Trials
4 Insulin Delivery - Pipeline Products under Development by Companies
4.1 Insulin Delivery Companies - Pipeline Products by Stage of Development
4.2 Insulin Delivery - Pipeline Products by Stage of Development
5 Insulin Delivery Companies and Product Overview
6 Insulin Delivery- Recent Developments
A selection of companies mentioned in this report includes:

• Abbott Diabetes Care Inc
• Aerami Therapeutics Holdings Inc
• AgVa Healthcare Pvt Ltd
• Alshifa Medical Syringes Manufacturing Co Ltd
• American Chemical Society
• AMF Medical SA
• Amrita Vishwa Vidyapeetham
• Andain, Inc
• Animas Corp
• ASTI Corp
• Avecho Biotechnology Ltd
• Becton Dickinson and Co
• Bigfoot Biomedical Inc
• Cambridge Consultants Ltd
• Cellnovo Ltd (Inactive)
• Companion Medical Inc
• Debiotech SA
• Defymed SAS
• Dermisonics Inc
• Diabeloop SA
• Eli Lilly and Co
• Embecta Corp
• Emperra GmbH E-Health Technologies
• EOFlow Co Ltd
• Erech Finance Cahalacha Ltd
• Glooko Inc
• GO-Pen ApS
• Harmonium Innovation SA
• Hospira Inc
• Houston Methodist Research Institute
• Imagine Medical Device Inc.
• InsuLenz
• Insulet Corp
• Iowa State University
• Kailian Medical Technology Co Ltd
• LifeScan Inc
• Massachusetts Institute of Technology
• Medical International Technologies (Mit Canada) Inc
• MedPro Safety Products, Inc.
• MedSolve Technologies, Inc.
• Medtronic MiniMed Inc
• Medtronic Plc
• MicroPort Scientific Corp
• MicroTech Medical Inc
• Modular Medical Inc
• Montmed Inc
• NanoDerma Ltd
• nGageIT Digital Health Inc
• Nitto Denko Corp
• North Carolina State University
• Novo Nordisk AS
• Open Medlabs Pvt Ltd
• Pennsylvania State University
• Perikinetics Inc
• Pharmasens AG
• Phluid Corporation
• PhysioLogic Devices Inc
• PositiveID Corp
• Qlibrium Inc
• Sanofi
• SFC Fluidics LLC
• Sooil Development Co., Ltd.
• Spring Health Solutions Ltd.
• Tandem Diabetes Care Inc
• TempraMed Israel Ltd
• Thermalin Inc
• Transdermal Specialties Inc
• University of KwaZulu-Natal
• University of Limerick
• University of Massachusetts Amherst
• University of Missouri-Kansas City
• University of North Carolina
• University of Toronto
• Univlabs Technologies Pvt Ltd
• Valeritas Inc
• ViCentra BV
• Vigmed Holding AB
• Washington University School of Medicine
• Wayne State University
• Ypsomed Holding AG
• Zealand Pharma AS
• Zenomics Inc

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

MENAFN12112024004107003653ID1108876652